Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Take it slow when increasing your dose as prescribed this helps minimize side effects
Yes, Ozempic can generally be used safely in patients with non-alcoholic fatty liver disease (NAFLD) and may actually improve liver fat content through weight loss and metabolic benefits
I cant wait to see my results after an entire month
To administer the medication, you place the injectable side of the pen directly on the skin of your abdomen, thigh, or upper arm, and then press the button at the other end of the pen
They produce greater weight loss, require weekly injections, and have broader NHS availability